Last deal

$100.M

Amount

Series B

Stage

06.01.2022

Date

2

all rounds

$130.M

Total amount

General

About Company
Virtue Diagnostics offers clinical solutions for infectious disease, cancer, maternal & fetal health, and chronic disease.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Virtue, Yikun Bio, 颐坤生物

founded date

01.01.2019

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

The company uses diverse technology platforms to offer treatment solutions from early screening to initial diagnosis, treatment monitoring, and management, and has a team of experienced leaders in Chemiluminescence, Clinical mass spectrometry, Multi-label pathology, Single-cell technology, and other Molecular biology technologies, coupled with automated workstation capabilities.
Contacts

Social url